To address these challenges, scientists use a combination of approaches. Physiologically based pharmacokinetic (PBPK) modeling is one method that uses mathematical models to simulate drug behavior in different species. Additionally, in-vitro studies with human cells can provide complementary data. Advances in molecular biology and genomics also offer insights into species-specific pathways and mechanisms of action, aiding in the refinement of extrapolation methods.
